Open AccessAbstract CT203: A phase II trial of ipilimumab in combination with nivolumab in EBV-associated advanced nasopharyngeal carcinoma (NCT03097939)
Author(s) -
Darren Wan-Teck Lim,
Quan Sing Ng,
RueyLong Hong,
Daniel S.W. Tan,
EngHuat Tan,
Boon-Cher Goh,
Wan Ling Tan,
Sarah Chan,
Shi Hao Tan,
HsiangFong Kao,
Gopalakish. Iyer,
MeiKim Ang
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct203
Subject(s) - medicine , nasopharyngeal carcinoma , nivolumab , ipilimumab , clinical endpoint , oncology , response evaluation criteria in solid tumors , phases of clinical research , chemotherapy , progression free survival , combination therapy , surrogate endpoint , clinical trial , gastroenterology , surgery , immunotherapy , radiation therapy , cancer